YscU C = C-terminal domain of YscU comprising amino acids 211-354 T3SS = type III secretion system Wiesand et al., 2008 Structure of YscU 2
We determined the crystal structures of the uncleaved variants N263A and N263D of YscU C at 2.05 Å and 1.55 Å resolution, respectively. The globular domain is found to consist of a central, mixed β-sheet surrounded by α-helices. The NPTH motif forms a type II β-turn connecting two β-strands. NMR analysis of cleaved and uncleaved YscU C indicates that the global structure of the protein is retained in cleaved YscU C .
The structure of YscU C variant N263D reveals that wild-type YscU C is poised for cleavage due to an optimal reaction geometry for nucleophilic attack of the scissile bond by the side-chain of Asn263. In vivo analysis of N263Q and H266A/R314A YscU variants showed a phenotype that combines the absence of translocator secretion with normal needle-length control. Comparing the structure of YscU to those of related proteins reveals that the linker domain between the N-terminal transmembrane domain and the autocleavage domain can switch from an extended to a largely α-helical conformation, allowing for optimal positioning of the autocleavage domain during injectisome assembly.
Introduction
The enteric pathogen Yersinia enterocolitica uses a sophisticated injection machinery called an injectisome to translocate effector proteins across eukaryotic cell membranes by type III secretion (T3S). This supramolecular structure, found in many Gram-negative pathogenic or symbiotic bacteria, including Salmonella spp., Shigella spp. and enteropathogenic Escherichia coli, is evolutionarily related to the bacterial flagellum. 1 A basal body consisting of several rings connected by a central rod spans the two bacterial membranes in both structures. [2] [3] [4] [5] The basal body bears an extracellular structure referred to as a needle 2, 3, [6] [7] [8] , pilus 9 or filament, [10] [11] [12] depending on the family of injectisomes. Upon contact with the eukaryotic host cell, a set of effector proteins that subvert host cellular functions to the pathogen`s benefit is translocated into the eukaryotic cytoplasm. The rotationally symmetric basal body of the T3S system (T3SS) actively exports the components of the extracellular needle structure. 3, 4, 15, 16 The length of the Yersinia injectisome needle, assembled from the 9-kDa protein YscF, differs from species to species. In Yersinia enterocolitica, the needle length of ~60 nm correlates with the length of the "molecular ruler" protein YscP. 17 A needle tip complex, made of the protein LcrV, 18 functions as a scaffold to assemble a pore in the target cell membrane consisting of YopB and YopD, through which T3SS effectors are translocated into the host cell. 19 Beside the "molecular ruler" model, 14 two other models for needle/hook length control, the cup model 20 and the molecular stopwatch mechanism, 21 are discussed. As a clear hierarchy in the synthesis of the needle components is not discernible, the T3SS presumably discriminates between substrate classes to assemble this complex molecular machine. 22 Needle assembly depends on the export of early substrates such as the needle subunit YscF and the molecular ruler YscP.
Thereafter, the system switches its substrate specificity to intermediate (translocators) and late (effectors) export substrates. The substrate specificity switch is thought to involve at least two proteins, the molecular ruler YscP and the inner membrane protein YscU. 23, 24 In the 40 kDa membrane protein YscU, four N-terminal transmembrane helices are followed by a globular cytoplasmic domain (YscU   C   ) . 25 The latter, which was originally been found in the C-terminal cytoplasmic domain of the Salmonella flagellar YscU homolog, FlhB, 26 is cleaved autoproteolytically within a conserved NPTH sequence. 27 Autocleavage, however, is abrogated by substituting either asparagine or proline by alanine. 27 Bacterial mutants carrying these substitutions no longer export translocator proteins (YopB, YopD and LcrV), whereas export of effector proteins is not affected.
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Cleaved YscU thus appears to discriminate between translocator and effector proteins. The mutant yscU N263A , furthermore, secretes less YscP and makes longer needles. 22 
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Here, we report the crystal structures of the non-cleavable YscU C N263A and YscU C N263D
variants from Yersinia enterocolitica and compare them to the related structures of EscU, SpaS 28 and Spa40. 29 Based on the structural information, additional YscU C mutants were designed to elucidate their in vitro autocleavage behaviour and the nature of the resulting in vivo phenotypes.
Results

Crystal structures of YscU C N263A and N263D
The YscU C variants N263A and N263D readily yielded well-diffracting tetragonal crystals. Crystallization of cleaved, wild type YscU C , by contrast, was not successful.
The structure of YscU C N263A was solved using SeMet-based multiwavelenght anomalous diffraction (MAD) phasing. Two (of four expected) selenium positions were sufficient to build an initial model, which was refined at a resolution of 2.05 Å ( Table 1) .
The isomorphous structure of YscU C N263D was correspondingly refined at a resolution of 1.55 Å (Table 1) . The globular domain of uncleaved YscU C ( Fig. 1) consists of a central, five-stranded, 
Structural basis for autocleavage of YscU
Close inspection of the modified NPTH motif in isosteric variant YscU C N263D (DPTH, The ideal entry angle for a nucleophilic attack of a carbonyl group has been proposed to lie between 100° and 110°, and a distance between nucleophile and electrophile of 2.5 Å. 30, 31 The corresponding angle of the YscU C N263D variant is 109° with an N-C distance of 2.8 Å. The β-amide nitrogen of Asn263 would therefore be positioned perfectly for a nucleophilic attack. Furthermore this geometric arrangement favours a stabilizing orbital overlap (Fig. 2b) , where the anti-binding σ*-molecular orbital (MO) of . The NMR-spectra of wild-type and N263A YscU C superimpose very well, with most peak positions being are virtually identical and line-widths apparently unaffected. Cleaved and uncleaved YscU thus share the same overall structure with minor, but physiologically highly relevant, changes in and close to the NPTH motif. ) has previously been reported to be pH-dependent 32 . YscU C variants N263D, P264G, P264A and H266A/R314A were therefore analysed at pH 9, 10 and 11 ( Fig. 4c) . In variant N263D, no cleavage was observed at higher pH-values, whereas P264G, P264A and H266A/R314A were partially cleaved only at elevated pH. These observations match the published data on FlhB P270A, 32 suggesting that the nucleophile Asn263 needs to be activated by deprotonation of its side chain amide group.
Fig. 4
YscU mutants that are not cleaved in vitro do not export the translocator LcrV
Next, the export of the LcrV protein in the corresponding Yersinia mutant strains was investigated. Secretion was not affected for wild-type YscU, and the variants H266A, R314A and R296A, but is lost in variants N263A, N263D, N263Q, P264A, P264G, and H266A/R314A, as confirmed by an immunoblot of the supernatant (Fig. 5 ). The LcrV secretion pattern is in excellent agreement with the data described above for in vitro autocleavage.
Fig. 5
The T3SS injectisome needle length is influenced strongly by YscU mutations
The influence of the YscU modifications on needle length was investigated by measuring needles from Y. enterocolitica ∆yscU mutant bacteria expressing the respective mutants in trans. Bacteria expressing wild-type yscU produced regulated needles of 69±10 nm. Similar needle lengths were measured for the YscU variants H266A (67±9nm), R314A (72±12nm), and R296A (76±11nm). In contrast, the length of needles in YscU variants N263A (125±40nm), N263D (143±51nm), P264A
(112±42nm), and P264G (114±30nm) was longer and less regulated. Interestingly, YscU variants N263Q (80±16nm) and H266A/R314A (77±15nm) were regulated with a length distribution slightly larger than that of wild-type YscU (Fig. 6 ). 
Discussion
YscU is poised for autocatalytic cleavage
To elucidate the structural basis of YscU C autocleavage, the crystal structures of YscU C variants N263A and N263D were determined at high resolution. Additional single-residue YscU C variants within the NPTH motif or its immediate vicinity were investigated with respect to their participation in cleavage and needle-length control. Protein cleavage gives rise to a labile succinimide, which is rapidly hydrolysed to yield a new C-terminal asparagine or iso-asparagine.
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Fig. 7
The structure of YscU C also explains phenotypes of previously reported YscU variants.
The strongly reduced export of the presumed inner rod protein YscI (in an yscPyscU mutant background) in the YscU variant Y317D implicates Tyr317 in interacting directly with YscI. 35 Structurally, this strictly conserved residue is fully exposed at the surface of α-helix 3. Presumably, the introduction of a negative charge prevents interaction with YscI explaining the observed phenotype. 28 The YscU variant G270N
has been reported to cause the complete loss of T3S and YscU autocleavage. Gly270, in the middle in β-strand II, is fully buried in the hydrophobic core of the domain. Replacing this by the significantly bulkier asparagine presumably prevents correct protein folding, resulting in the loss of this protein and non-functional T3SS. (Fig. 8b) , despite a low level of overall sequence identity (Fig. 8a) .
Needle length in a non-cleavable YscU mutant is controlled even without YscP over-expression
Fig. 8
An obvious difference between YscU C and its homologues EscU C , SpaS C and Spa40 C involves the proposed flexible linker (211-248) connecting the globular autocleavage domain to the N-terminal membrane-spanning four-helix bundle (Fig. 8b) . In YscU C , amino acids 232-244 form a well-defined α-helix, which is not observed in the homologous structures. In the crystal structure of YscU C , α-helix α0 is involved in a crystal contact to α-helix α4 of the next monomer. One of the crystal forms of EscU C additionally reveals a further α-helix (α-1) N-terminal of α0. 28 The presence of α-helix α0 confirms earlier predictions of the secondary structure for the flagellar protein FlhB. 37 The linker region is essential for T3S. 28 
Materials and Methods
YscU in vivo experiments
Bacterial strains, plasmids and genetic constructions are given in Supplementary Data Table 1 . E. coli Top10 was used for plasmid purification and cloning. Bacteria were grown routinely on Luria-Bertani (LB) agar plates and in liquid LB-medium. Ampicillin was used at concentrations of 200 µg/ml. 
Supp. 1
Plasmids were generated using either the Pfu turbo polymerase (Stratagene) or Vent DNA polymerase (New England, Biolabs). Oligonucleotides for genetic constructs are given in Supplementary Data Table 2 . All constructs were confirmed by sequencing using a 3100-Avant genetic analyser (ABI Prism).
Supp. 2
LcrV secretion and immunoblotting
Induction of the yop regulon was as described by Cornelis et al.. 38 
Electron microscopy
Needles were visualized by transmission electron microscopy as described. 8, 23 . After , as well as 15 N-labelled YscU C wild type were as described. 39 YscU C mutations were introduced using the QuikChange kit (Stratagene) and verified by DNA sequencing (GATC, Konstanz, Germany). YscU C variants were purified as described above.
Preparation of pH-dependet cleavage
The different YscU C variants were expressed and purified as described above. P264A
was dialysed against 25 mM Ches-buffer, 100 mM NaCl for 3h at room temperature.
P624G, H266A/R314A and N263D were dialysed against 25 mM CAPS-buffer, 100 mM NaCl for 4h at room temperature. Afterwards, the solution of protein P264G
was stored for 48 h and H266A/R314A and N263D were stored for 24 h at 4 °C.
Cleaved proteins were submitted to SDS/15% PAGE and stained with Coomassie brilliant blue. at beamline X12 at the EMBL Outstation (Hamburg, Germany) and processed with the HKL2000 40 and MOSFLM. 41 Localization of two selenium sites, which were used for phasing and the generation of a partial model, was done with AUTORICKSHAW. 42 Manual model building was carried out using COOT 43 and refinement was completed using REFMAC5.
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The X-ray data set of YscU C N263D was collected at ESRF beamline ID29 (Grenoble, France), processed with MOSFLM 41 and scaled with SCALA. 45 Using REFMAC5 46 and SeMet-labelled YscU C N263A as a phasing model, the structure was solved by difference fourier and further refined with COOT 43 and REFMAC5. 44 The validation of both structures was done with MOLPROBITY. 47 Data collection and refinement statistics are given in Table 1 . Figures were prepared using PYMOL (http://pymol.org).
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Tab. 1
NMR Analysis
For NMR spectroscopy, we used a 12 mg/mL solution of uniformly 15 
